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ABSTRACT
Background Rapid discharge strategies for patients 
with low- risk chest pain using high- sensitivity troponin 
assays have been extensively evaluated. The adherence 
to, and acceptability of such strategies, has largely 
been explored using quantitative data. The aims of 
this integrated qualitative study were to explore the 
acceptability of the limit of detection and ECG discharge 
strategy (LoDED) to patients and health professionals, 
and to refine a discharge information leaflet for patients 
with low- risk chest pain.
Methods Patients with low- risk chest pain who 
consented to a semi- structured interview were 
purposively sampled for maximum variation from four of 
the participating National Health Service sites between 
October 2018 and May 2019. Two focus groups with 
ED health professionals at two of the participating sites 
were completed in April and June 2019.
Results A discharge strategy based on a single 
undetectable hs- cTn test (LoDED) was acceptable to 
patients. They trusted the health professionals who 
were treating them and felt reassured by other tests, 
(ECG) alongside blood test(s), even when the clinical 
assessment did not provide a firm diagnosis. In contrast, 
health professionals had reservations about the LoDED 
strategy, including concern about identifying low- risk 
patients and a shortened patient observation period. 
Findings from 11 patient interviews and 2 staff focus 
groups (with 20 clinicians) centred around three 
overarching themes: acceptability of the LoDED strategy, 
perceptions of symptom severity and uncertainty, and 
patient discharge information.
Conclusion Rapid discharge for low- risk chest pain 
is acceptable to patients, but clinicians reported some 
reticence in implementing the LoDED strategy. Further 
work is required to optimise discharge discussions and 
information provision for patients.
INTRODUCTION
High- sensitivity troponin (hs- cTn) testing has led 
to an increasing drive to discharge low- risk patients 
who have presented to the emergency department 
(ED) with suspected cardiac chest pain soon after 
chest pain onset.1 We recently reported a pragmatic 
multicentre randomised controlled trial (RCT) 
which evaluated the clinical effectiveness of a single 
hs- cTn taken on arrival in the ED, in combination 
with a non- ischaemic ECG and irrespective of chest 
pain onset time (the limit of detection and ECG 
discharge strategy: LoDED).2 This strategy facili-
tated safe early discharge in over 40% of patients 
with low- risk chest pain.
Previous interventional studies evaluating novel 
rapid discharge strategies have demonstrated poor 
adherence by clinicians when embedded within 
usual care, reducing their clinical effectiveness.3 4 
Adherence to a diagnostic strategy is clinician led 
and largely driven by concerns around risk and 
safety.4 Such barriers to effective implementation 
require further exploration.4 Quantitative data 
from trials demonstrate poor adherence and fail to 
explain why this occurs in practice.4–7
Acceptability of rapid discharge strategies is a 
shared construct between clinicians and patients 
and may influence adherence.5 It is known that 
acceptability can be improved using a shared 
decision- making model where written information 
provided to patients can improve patient knowl-
edge, reduce decisional conflict and increase trust 
Key messages
What is already known on this subject
 ► High- sensitivity cardiac troponin assays can 
facilitate the very early discharge of patients 
with chest pain from the ED.
 ► Adherence to rapid rule- out strategies has been 
previously explored in interventional trials using 
quantitative data.
What this study adds
 ► A discharge strategy based on a single 
undetectable high- sensitivity troponin test is 
acceptable to patients with low- risk chest pain.
 ► Patients trust the clinicians’ decisions and 
accept the lack of a firm diagnosis; they also 
appreciate written discharge information.
 ► Health professionals are uncertain about the 
accurate identification of low- risk patients 
and concerned that the shortened observation 
period, associated with a single undetectable 
high- sensitivity troponin rule- out strategy, 
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with a consequent decrease in downstream resource use.4–7 
Exploring acceptability of a rapid discharge strategy with both 
clinicians and patients is likely to illuminate adherence and clin-
ical practice. Written discharge information has been shown to 
reduce anxiety in patients with acute chest pain and may conse-
quently improve acceptability.8 However up- to- date research is 
required to refine discharge information in the era of hs- cTn 
testing.1
This integrated qualitative study aimed to explore the accept-
ability of the LoDED strategy to patients and health profes-
sionals involved in the trial and to refine discharge information 
for patients with low- risk chest pain.
METHODS
Patient semi-structured interviews
Detailed inclusion and exclusion criteria for the LoDED trial 
have been published previously.9 Patients were eligible to partic-
ipate in semi- structured telephone interviews if they attended 
the ED with chest pain, and their initial hs- cTn result was below 
the limit of detection (LoD), that is, those patients whose care 
would potentially be altered by trial enrolment and who were 
assessed as being low risk of subsequent (30 days) major adverse 
cardiac events. Low- risk patients in both the LoDED interven-
tion and usual care arms were eligible for interview if they had 
consented to enrolment in the main RCT. Consent to contact 
for the interview was recorded on a central database, and the 
qualitative researcher contacted patients from six of the eight 
National Health Service (NHS) trial sites. Participants were 
contacted to take part in an interview within 90 days of index 
admission but after the 30 days outcome follow- up for the main 
RCT had been completed. Participants were purposively sampled 
for maximum variation (age, gender, and socioeconomic status). 
Most patients were selected from the LoDED intervention arm 
to explore acceptability of the new early discharge strategy. 
Two patients from the usual care arm were also interviewed to 
explore views about usual practice. Interviews explored experi-
ences of patients’ stay in the ED, acceptability of early discharge, 
positive and negative aspects of their ED care, and their views 
on the discharge information leaflet for patients with low- risk 
chest pain. Interviews were conducted with participants from 
four NHS trial sites.
Healthcare professional focus groups
Focus groups were conducted with health professionals from 
two of the eight participating trial sites. Both sites used serial 
hs- cTn testing over 2–3 hours as a control diagnostic strategy 
during the RCT. Health professionals were purposively 
selected for maximum variation in terms of gender, clinical 
background and varied levels of seniority. We also included 
general practitioners (GPs) working in the ED to gain a 
primary care perspective. All participating health professionals 
provided written consent and had recruited and/or treated 
patients during the trial. The focus groups aimed to explore 
their views about identifying, treating and discharging patients 
identified as low risk through the LoDED strategy, and their 
views on the discharge information leaflet for patients with 
low- risk chest pain.
Separate topic guides were used for the interviews and focus 
groups; these were developed in collaboration with Patient 
Advisory Group (PAG) members prior to data collection. LB 
conducted all the interviews and JI facilitated the focus group 
discussions with support from LB and EC.
Patient discharge information leaflet
Prior to trial commencement, we designed a bespoke patient 
discharge information leaflet with input from our PAG. This 
included a risk heuristic adapted from a previous interven-
tional trial exploring shared decision- making,10 11 together with 
information on symptoms of myocardial infarction, the testing 
that was undertaken and ‘safety- netting’ advice. Refinement of 
discharge information drew on data from the interviews and 
focus groups. The discharge leaflet was given to all patients and 
health professionals prior to interview and focus group discus-
sions. Detailed feedback was solicited during interviews and 
focus groups, particularly in relation to patients’ understanding 
of the risk heuristic, and whether changes should be made to 
improve the leaflet. PAG members also reviewed and commented 
on amendments made to the leaflet after the qualitative feed-
back provided by patients (via semi- structured interviews) and 
health professionals (via focus groups). Figure 1 shows the final 
amended leaflet.
Data analysis
Interviews and focus groups were recorded and transcribed 
verbatim by a professional transcription service. Thematic anal-
ysis of the data was an ongoing and iterative process using NVivo 
software to organise and code the transcripts.12 Transcripts were 
initially coded by the qualitative researcher (LB). Codes and 
themes were developed and discussed with the lead qualitative 
researcher (JI) at regular intervals during data collection and 
analysis to achieve consensus. Two interview transcripts were 
also read and coded by an independent qualitative researcher 
(DJ) to compare and discuss the coding framework. Frame-
work analysis was used to compare codes and themes across the 
patient and health professional data sets, encompassing similar 
(and contrasting) themes and findings.13 These approaches were 
inductive since they did not use predefined coding categories.
Patient and public involvement
The RCT had a PAG comprising four members who met on 
four occasions to advise the management team. The PAG were 
consulted at the point of analysis and interpretation of the data 
from this study, with findings presented in lay terms at a PAG 
meeting. They also gave detailed feedback on the revised version 
of the patient discharge leaflet. The patient and public involve-
ment lead is a co- author of this paper.
RESULTS
Patient semi-structured interviews
One hundred and seven low- risk patients consented to contact 
and 52 were contacted by the qualitative researcher. Of those 
contacted, 11 patients from 4 sites were interviewed between 
October 2018 and May 2019: 9 patients from the LoDED inter-
vention arm and 2 from the usual care arm. Six interviewees 
were women (54.5%); mean age was 53 years. Patients who took 
part in interviews were slightly older than the low- risk patient 
subgroup who participated in the main RCT. Five participants 
were from the least deprived areas (deprivation measured by 
postcode), four from areas of high deprivation and two from 
areas with average deprivation in the UK (indices of multiple 
deprivation decile).14 15 Interviews were conducted at a median 
of 72 days (IQR 65–78 days) post initial ED attendance. Table 1 
shows demographic details for those interviewed compared with 
all low- risk patients in the LoDED cohort.
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Healthcare professional focus groups
Twenty ED health professionals consented to involvement in two 
focus groups, which were conducted in April and June 2019. 
Focus groups were scheduled on days when a varied group of 
health professionals were available, incorporating a wide range 
of experience in emergency care, nursing, and GPs working in 
the ED. Some staff travelled to attend on a non- working day 
and cover was provided for others to attend, thus ensuring that 
the groups were representative. Table 2 provides details of those 
who participated in focus groups, including their gender and job 
title.
Thematic analysis: patient and health professional themes 
and sub-themes
Three overarching themes were identified, describing both 
patient and health professionals’ acceptability of the LoDED 
strategy (table 3). In the quotations, patients are identified by 
ID number, gender, age, and study arm (LoDED intervention 
or usual care) and health professionals by ID number, broad job 
title, gender and focus group site.
Figure 1 Leaflet for low- risk chest patients to take home following discharge. NHS, National Health Service.
Table 1 Demographics and clinical characteristics of patients with 
an initial high- sensitivity troponin (hs- cTn) level below the limit 
of detection (LoD) in the randomised controlled trial cohort and 
qualitative interview sample




LoDED intervention arm 141 (51.5%) 9 (81.8%)
Mean age 46 years 53 years
Gender: female 144 (52.5%) 6 (54.5%)
Gender: male 130 (47.5%) 5 (45.5%)
Ethnic origin: white 228 (84%) 11 (100%)
Chest pain history (clinician reported)
Slightly suspicious 175 (64%) 6 (54.6%)
Moderately suspicious 77 (28%) 4 (36.4%)
Highly suspicious 22 (8%) 1 (9%)
Successful early discharge† 165 (61.3%) 9 (82%)
Median LOS hours (IQR)† 3.7 (2.8–5.2) 3.5 (2.7–3.8)
*Low- risk patients were those with an initial hs- cTn below the LoD and a non- 
ischaemic ECG in either trial arm.
†Successful early discharge data available for 269/274 low- risk patients.
‡Length of stay (LOS; hours) data available for 268/274 low- risk patients.
LoDED, limit of detection and ECG discharge strategy.
Table 2 Demographics of health professionals who took part in 
focus groups




Gender: female 3 (33.3%) 7 (63.7%)
Gender: male 6 (66.7%) 4 (36.3%)
ED doctors (varied levels of seniority) 5 (55.6%) 8 (72.7%)
Nursing staff 3 (33.3%) 1 (9.1%)
GPs 1 (11.1%) 1 (9.1%)
Healthcare assistant 0 1 (9.1%)
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Theme 1: acceptability of single blood test (LoDED) strategy
Trust and reassurance
Most patients stated that they felt the LoDED strategy was accept-
able and this was influenced by having trust in the treating health 
professionals, feeling reassured by other tests, such as an ECG, and 
the practicalities associated with having blood tests taken:
If this is the way things work [one blood test] they know in the 
hospital better than we do. I thought it was quite a good idea to do 
that… I felt comfortable that people knew what they were doing 
(Patient_27, Female, 69 years, LoDED Intervention arm)
After the ECG I was absolutely fine, because they told me that’s 
fine, it must be something else (Patient_25, Male, 45 years, LoDED 
Intervention arm)
Some patients highlighted that more time spent ‘hanging 
around’ in the ED was potentially stressful for them and for their 
wider family, and a ‘waste of time’ if they had been identified as 
being in a low- risk group:
To wait potentially for another two hours when the first results 
come back as under the risk level seems that’s more time for you to 
sit and worry… if you have to keep doing another set of tests just 
to quantify something when your first test already comes out as low 
it seems a bit of a waste of everybody’s time, and resources really 
(Patient_23, Female, 58 years: LoDED Intervention arm)
Health professionals acknowledged that having serial blood 
tests could be anxiety provoking for patients who had chest pain, 
and adapted to the LoDED strategy by rationalising that most 
patients would be unaware of a change from serial sampling to a 
single test strategy (LoDED):
…you’re confident that first blood test is okay, then should we be real-
ly offering this kind of…[two blood tests] I think especially the group 
of patients that may come in with chest pains is anxiety related, we 
are just going to add to that… (ED nurse_7, Female: Focus group 1)
I don’t necessarily think that patients have got the expectation 
of serial investigation. So they come in and have some tests done 
which is what they are expecting, but then I don’t think they are 
planning on spending several hours hanging around in the emer-
gency department … (ED doctor_4, Male: Focus group 1)
Reservations and anxieties
In contrast to patients, it was health professionals who had reserva-
tions about moving towards a single test strategy, despite attempts 
to rationalise and adapt to the single test strategy. Health profes-
sionals pointed out that they felt uncomfortable with the LoDED 
strategy because it was a change in practice. However, two health 
professionals saw the LoDED strategy as a progression in the field 
of medicine, highlighting the way in which testing evolves and 
changes over time in parallel with career progression:
The evolution of testing throughout my career and how things 
have changed and when one test replaced another test, it’s not like 
the patients are coming in having no investigations done, they are 
going to have as a minimum if we’re wanting to rule out cardiac 
related chest pain an ECG, and blood tests (ED doctor_4, Male: 
Focus group 1)
I think it probably makes clinicians feel more uncomfortable than 
the actual patients, … because most patients aren’t going to know, 
and it’s not like we’re still not being just as thorough, it’s just a dif-
ferent way of monitoring (GP_3, Female: Focus group 1)
Most health professionals highlighted some reservations or 
unanswered questions about using the one blood test pathway 
and reliance on tests in a ‘usual care’ environment. Reservations 
largely centred around how to identify and differentiate between 
low- risk, medium- risk and high- risk patients:
For me it’s about properly identifying a low- risk patient group in 
whom we know there’s a less than 5 % risk of them having an acute 
coronary syndrome before you ever do a troponin. So if you’ve 
already identified the right group then I would be happy with the 
LoDED protocol.…One of my concerns is that there will be ad-
mission creep and actually we’ve started to put people on it who 
are nowhere near low risk, their history of ischaemic heart disease, 
their ECG looks fine, they presented with discrete chest pain and 
they are not in pain anymore (ED doctor_18, Male: Focus group 2)
A reservation in relation to the LoDED strategy was its use by 
those with limited clinical experience (in years and expertise) 
who might rely too heavily on one blood test, further impacted 
by the shortened observation period associated with the pathway 
that could lead to early discharge of a high- risk patient:
I’ve just got a niggling concern that sometimes chest pain is viewed 
as, so long as your troponin is negative then you’re home and dry, 
… and currently I guess with the six hour pathway we have this 
window to observe the patient on the CDU… to give the junior 
clinician some time to see that patient and let those diagnostic 
thoughts happen (ED doctor_14, Male: Focus group 2)
In contrast, it was also pointed out that a lack of continuity 
of care associated with multiple diagnosing and treating health 
professionals using the serial testing strategy, could contribute to 
missing a serious diagnosis and early discharge:
I am not sure to what degree they get a thoughtful review with 
the second one [troponin test result]. I suspect if we make the dis-
Table 3 Patient and health professional themes and sub- themes
Theme Patients Health professionals
Acceptability of single blood test 
(LoDED) strategy
Trust and reassurance
Having trust in the treating health professionals
Feeling reassured by the number of other tests alongside blood 
test(s)
Practicalities and reduced anxiety
Reservations and anxieties
Identifying low- risk patients
Lack of clinician experience
Shortened observation period
Perceptions of symptom severity and 
uncertainty
Identification and experience of chest pain
Lack of a firm diagnosis
Understanding of being a low- risk chest pain patient
Legitimate use of NHS services
Ambiguity: diagnosis and ongoing management of ‘low- risk’ 
chest pain symptoms
Explaining risk and uncertainty to low- risk patients
Acceptance: a small number of low- risk patients may have a heart 
attack in the future
Lack of follow- up after ED attendance
Patient discharge information Patients valued written information
Readability and clarity
Acceptable level of risk communicated
Lack of current discharge information for patients with low- 
risk chest pain
Fills an information gap for low- risk chest pain patients
LoDED, limit of detection and ECG discharge strategy.
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charge decision when the patients actually are in front of us in the 
department… that might be an advantage of doing it sooner. At the 
moment they do get quite dislocated from the clinician who made 
the initial assessment… (ED doctor_19, Male: Focus group 2)
Theme 2: perceptions of symptom severity and uncertainty
Identification and experience of chest pain
Patients described uncertainty about the severity of their symp-
toms, and whether or not pain was indicative of myocardial 
infarction or something less serious. All had experienced some 
form of chest, muscle pain or ‘tightness’ in the chest; some also 
reported a cold sweat, dizziness and feeling sick; patients carried 
out their own ‘risk assessment’ with some deciding to go to the 
ED themselves, others were told by family or colleagues that 
they should attend:
I came into work and I had chest pains, and it was peculiar because 
it didn’t really feel like anything I had felt before, and I spoke to 
some people at work about it and… went through this first aiders 
test and they said the best thing to do really is just to go into ED… 
(Patient_12, Male, 50 years: LoDED Intervention arm)
I just came over a little bit dizzy, felt a little bit sick, so I just stopped 
and leaned over the trolley and it passed away, and I thought at 
the time actually it was more a panic thing rather than anything 
else, but obviously the pain was worrying me so then I decided I 
had better do something about it… (Patient_27, Female, 69 years: 
LoDED Intervention arm)
Uncertainty was also reflected in patients’ diagnosis when they 
attended the ED. Most patients were not given a firm diagnosis 
after their ED assessment. Some were provided with ‘potential’ 
non- cardiac diagnoses (eg, anxiety, muscle pain); others were 
not, but they accepted this either because their symptoms had 
reduced during their time in the ED, or they drew their own 
conclusions about symptoms based on pre- existing health condi-
tions (panic attack) or the ageing process:
He [the clinician] just seems to think it was muscle strain in the 
chest (Patient_29, Male, 37 years: Usual Care arm)
At the end of the time [in ED] I was more realistic in terms of 
the fact of thinking it was a panic attack… if I hadn’t realised that 
then I probably would have been a bit more anxious (Patient_23, 
Female, 58 years: LoDED Intervention arm)
I thought well I’m getting older now, maybe this is what happens 
as you get older… aches and pains about something that’s nothing 
(Patient_12, Male, 50 years: LoDED Intervention arm)
None of the patients recalled explicit conversations about 
their current ‘risk’ or specifically being a low- risk patient, but 
having received the discharge leaflet some perceived that they 
were not ‘at risk’ and knew what to do if they had similar symp-
toms in the future:
Only in terms of the fact that the results came back that they didn’t 
think I was a risk… just to give me the leaflet and say if I did have 
any… if I did start to have any symptoms etc, then to just [do] what 
I had done before and call (Patient_23, Female, 58 years: LoDED 
Intervention arm)
LoDED intervention patients consistently highlighted the 
importance of appropriate and legitimate NHS use, they did not 
want to waste health professionals time, or use NHS resources 
unnecessarily. The rapid rule out strategy reinforced cost effec-
tive use of time and NHS resource:
I didn’t want to waste their time at the end of the day, I just wanted 
a quick answer, but they were very thorough in they weren’t going 
to just let me leave after an hour, they said no we need to check this 
(Patient_6, Male 53 years: LoDED Intervention arm)
you didn’t have to do a second blood test, it’s a waste of time and 
money (Patient_25, Male 45 years: LoDED Intervention arm)
Ambiguity: diagnosis and ongoing management of ‘low-risk’ chest 
pain symptoms
Some health professionals discussed the reasons why they could 
not always give a firm diagnosis when providing explanations 
for chest pain, specifically when ECG and troponin tests are 
normal. They felt they often discussed this diagnostic ambiguity 
with low- risk patients:
when it comes to discharge explanations it’s often that we don’t 
give a diagnosis, and I tend to use the ‘ we have ruled out this, 
this and this, and it is probably just something muscular and you 
don’t need to worry about it. But of course it’s a safety netting spiel 
here…” (ED doctor_4, Male: Focus group 1)
I think people don’t like being sent away without absolute it’s this, 
and we don’t always know, and sometimes we have to say we don’t 
know but we’ve ruled out these emergency situations… (ED doc-
tor_5, Female: Focus group 1)
Nursing staff from one focus group reported that patients 
often wanted more explanation when they have been told by a 
doctor that their condition was ‘not cardiac’:
I think from the nursing point of view quite often once the doctor 
has been in there and told them that it’s not cardiac,… they will 
be saying to us, ‘’what is it then?” and I just usually say well, we’re 
pretty sure that it’s not cardiac related. But quite often, especially 
with the older people, don’t like to ask the doctors questions so 
they will ask us (ED nurse_7, Female: Focus group 1)
A research nurse from the second focus group felt that she 
simply reiterated ‘what was happening’ in ‘layman’s terms’:
So I think all I probably did was reiterating in slower terms may-
be more layman’s terms what the process is that they are going 
through… and confirmed for them what’s happening (Research 
nurse_13, Female: Focus group 2)
Some health professionals reported a lack of follow- up for 
patients with low- risk chest pain after discharge from the ED. 
Although EDs routinely transfer records to a patient’s GP 
informing them that they have attended for chest pain, many 
acknowledged that these patients would not be formally followed 
up in primary care and the onus would be on the patient to make 
an appointment with their GP after attending the ED should 
they believe it necessary to do so:
Sometimes we do get patients who have been to ED with chest pain 
and then no follow- up, …… and they get sent back to GPs as the 
mop it up… (GP_3, Female: Focus group 1)
The wider impact of a one test strategy was discussed in the 
context of; lack of resource in primary care to follow up patients 
with low- risk chest pain, strain on NHS resources, changes in the 
way the general public use healthcare and a changing distribu-
tion of workload across the NHS:
I see a lot of chest pain in GP world… I think GPs are very stretched 
at the moment and a lot of people are leaving general practice be-
cause they are seeing a patient every ten minutes, I think it’s very 
difficult to take a chest pain history in ten minutes and do every-
thing, I don’t have the resources (GP_3, Female: Focus group 1)
We do know that [ED] crowding kills, and it is really important, 
and the ambulance service is hugely stretched, and if we’re send-
ing the message that if you get any kind of chest pain, you ring 
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an ambulance because this might be really serious, and you go to 
ED… even if you are sending them home early… what risk are you 
putting on everyone else in that department (ED doctor_4, Male: 
Focus group 1)
Theme 3: patient discharge information
Patients valued written information
Most patients appreciated having written information they could 
take with them when they left the ED, to read in their own time. 
The discharge leaflet was clear, easy to understand and reassured 
most patients. Many patients did not recall any discussion of the 
leaflet with the clinical team at discharge and could not find, 
or had not kept, a copy of the leaflet they had been given at 
discharge. One patient gave the leaflet to their partner to read, 
but most did not share the information with other members of 
their immediate family:
I think it was just the fact that it was really well written, and it 
put your mind at rest, because there’s going to be a lot of people 
including myself that are thinking I don’t know. But I really read it 
in- depth (Patient_15, Female, 56 years: LoDED Intervention arm)
I think it’s better to have a leaflet than just verbal, because I think it 
cements it in a little bit better than just someone’s… what feels like 
someone’s opinion if you like (Patient_12, Male, 50 years: LoDED 
Intervention arm)
Patients felt that the leaflet conveyed an acceptable level of 
risk, provided contact information should they need it, and felt 
reassured that they were not likely to have a myocardial infarc-
tion in the near future:
The takeaway [message] for me was everything is fine, and then 
almost instantly my brain let it go… I look at it as 1 % is like zero 
really, I am in the clear, that’s the way I felt about it (Patient_12, 
Male, 50 years: LoDED Intervention arm)
Lack of current discharge information for patients with low-risk 
chest pain
Feedback about the discharge leaflet from health professionals 
was largely positive; they felt it was appropriate for future use 
in the general population of patients with low- risk chest pain. 
Health professionals liked the layout, the ‘clear’ risk heuristic 
and highlighted the lack of existing written information avail-
able in routine care for patients with low- risk chest pain:
I think it’s interesting that we don’t hand out discharge informa-
tion. We do for so many other things, pretty much every condition 
that comes through minors has got it, but here is this potentially 
life- threatening problem on the way in, and we don’t give them 
anything to say this is what the doctor has assessed so what we 
think (ED doctor_4, Male: Focus group 2)
Health professionals offered some useful suggestions regarding 
the wording and layout of the leaflet, including the addition 
of QR codes and links to national websites. A revised version 
of the leaflet was reviewed by our PAG to finalise the content 
and layout. Minor changes were made to wording to clarify the 
advice and the final version is shown in figure 1.
DISCUSSION
This qualitative study has shown that a discharge strategy based 
on a single undetectable hs- cTn test (LoDED) was acceptable to 
patients. Patients trusted the clinicians’ decision and were reas-
sured by the other tests carried out. They also accepted the lack 
of a firm diagnosis, understood that they were at ‘low- risk’, did 
not want to waste NHS resources and appreciated the written 
leaflet given on discharge. Health professionals were uncer-
tain about the accurate identification of low- risk patients and 
concerned that the shortened observation period associated with 
the LoDED strategy could lead to the early discharge of high- risk 
patients. However, some suggested that an informed discharge 
discussion is important, and facilitates safe early discharge. 
Positive framing and information provision around normal test 
results has been shown to improve reassurance, yet this issue 
remains underexplored in emergency medicine literature.16
Health professionals also highlighted pressure placed on the 
ED due to increased patient numbers and a lack of follow- up 
for patients with low- risk chest pain after ED discharge due 
to current resource pressures in primary care. However, the 
LoDED RCT found that up to 50% of low- risk patients in both 
trial arms visited their GPs within 30 days of attending the ED.2 
This may have been due to the lack of a firm ED diagnosis for 
their chest pain which concerned patients and health profes-
sionals alike. Previous research has highlighted that ED health 
professionals tend to focus on the exclusion of cardiac- related 
causes of chest pain, rather than the ‘positive management of 
non- cardiac chest pain’.17 While reassurance may be important, 
it may be ineffective for patients with non- cardiac chest pain.18 
Further interventions such as brief cognitive therapy have been 
evaluated but are not recommended in unselected non- cardiac 
chest pain patients.18 Therefore, further mixed- methods research 
is required to establish the optimal approach to discharge discus-
sions, shared decision- making and information provision in this 
patient group.
This analysis also raises other important considerations for the 
clinical implementation of very rapid rule- out strategies based 
on hs- cTn testing. These include an over reliance on the hs- cTn 
test itself, a lack of consideration of alternative serious diagnoses 
and the clinical experience of clinicians making the discharge 
decision. The diagnostic literature in this field tends to recruit 
only patients in whom an acute coronary syndrome is suspected 
and excludes patients in whom an alternative serious diagnosis 
is suspected; as a result these issues are poorly understood. One 
exploratory study has shown improved diagnostic work- up 
when patients are assessed by more senior ED clinicians,19 and 
to mitigate these issues we therefore recommend that a robust 
‘senior sign- off ’’ process is put in place, as proposed by the 
Royal College of Emergency Medicine.20
A limitation of this qualitative study is the small sample size; 
however, no new themes were arising from the data and satu-
ration was reached. Although a high proportion of low- risk 
patients were contacted to take part in the qualitative study 
(48.6% of those who provided consent), only 21.2% agreed 
to an interview. Interviews were conducted after the 30 days 
outcome follow- up had been completed, but on average low- risk 
patients completed this outcome measure 67.7 days after they 
attended the ED. Patients therefore took part in interviews more 
than 2 months after trial participation, and this may have nega-
tively impacted patients’ willingness to participate in an inter-
view and recall the details of their attendance. A limiting factor 
that may have introduced bias to the focus group sample was 
that work commitments may have limited health professional’s 
availability to attend on the scheduled day and time. Bringing 
professionals with different levels of power together in the same 
focus group (eg, consultants and nursing staff) may introduce 
power dynamics and bias (eg, nursing staff feel less empowered 
to air their views and opinions). However, members of nursing 
staff and the healthcare assistant who attended focus groups all 
aired their views and were not apprehensive about discussing 
their experience and views of LoDED.
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CONCLUSIONS
Rapid discharge in patients with low- risk chest pain is accept-
able to patients, but clinicians reported some reticence in 
implementing the LoDED discharge strategy. Key factors in the 
successful implementation of rapid discharge strategies are likely 
to be (1) taking the time to discuss what it means to be ‘low- 
risk’, (2) acknowledging and explaining diagnostic ambiguity 
to patients and (3) improved verbal and written information 
provision.
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